#OncologyFrontier Archives

CSCO 2024 | Dr. Feng Shen: Witnessing CSCO’s Glorious Journey, Contributing to the Advancement of Personalized Surgical Treatment for Hepatobiliary Tu

By Peng Longmei 2024.10.27

Editor's Note: From September 25 to 29, 2024, the 27th National Clinical Oncology Conference and the 2024 CSCO Annual Academic Meeting, co-organized by the Chinese Society of Clinical Oncology (CSCO)…

Dr. Yuan Yu’s Insights: Advances in Esophageal Cancer Nursing and Future Directions for Enhanced Recovery | CACA Integrated Esophageal Cancer Academic

By Peter W. PENG 2024.10.26

Editor's Note: At the 2024 CACA Integrated Esophageal Cancer Academic Conference, Dr. Yuan Yu, the inaugural chairman of the CACA Committee on Integrated Nursing for Esophageal Cancer and a leading…

CSCO 2024丨Dr. Hui Zhou: Challenges and Advances in Lymphoma Diagnosis and Treatment, from Standardization to Innovation

By Peng Longmei 2024.10.25

From September 25 to 29, 2024, the 27th Annual National Clinical Oncology Conference and 2024 CSCO Annual Meeting, hosted by the Chinese Society of Clinical Oncology (CSCO) and Beijing HopeRun…

EAU24 Interview | Dr. Jianming Guo and Dr. Riccardo Campi Discuss Renal Cancer Surgical Treatments

By Mourabit Halima 2024.04.21

Editor's note: The 39th annual meeting of the European Association of Urology (EAU24) took place from April 5th to 8th, in Paris, France, focusing on global urological oncology hot topics…

ASCO-GU Interview | Dr. Yige Bao Shares Progress in PARPi Precision Treatment of Prostate Cancer and His Team’s Research on Neoadjuvant Therapy for UTUC

By Mourabit Halima 2024.03.07

Editor's Note: The annual American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU) was recently held in San Francisco, USA. Over its twenty-year history, the ASCO-GU Symposium has witnessed the…

ASCO-GU Interview | Dr. Xuefeng Qiu: Timely Testing and Treatment, Let mCRPC patients benefit more from PARPi precision treatment

By Mourabit Halima 2024.03.06

Editor's Note: The annual American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU 2024) was held in San Francisco, USA, from January 25 to 27, 2024. The conference presented updates…

ASCO-GU Interview | Dr. Tao Xu: Current status of precision treatment of prostate cancer and application of genetic testing

By Mourabit Halima 2024.03.05

Editor's Note: On January 25, 2024, the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU) marked its 20th anniversary in San Francisco, USA. On the occasion of the 20th…

The Future of Hematology: Expert Insights from EHA Conference

By Mourabit Halima 2024.02.23

Discover the latest advancements in hematology with our video series covering the European Hematology Association conference. This series offers a comprehensive analysis of pivotal studies such as the A031501/AMBASSADOR trial,…

WCLC Interview | Dr. Clarissa Baldotto: Treatment strategies after failure of immunotherapy for lung cancer

By Mourabit Halima 2024.02.13

The 2023 World Conference of Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), was grandly held in Singapore from September 9th to 12th. At the WCLC conference, Dr. Clarissa Baldotto, President of the Brazilian Group of Thoracic Oncology, was invited by “Oncology frontier” to talk about the treatment strategies for lung cancer after immunotherapy failure, as well as the current status and future development of oncology in Brazil.

WCLC Interview | Dr. CaiCun Zhou Interprets Important Researches and Future Trends in the Field of ADC

By Mourabit Halima 2024.02.13

Editor's Note: The 2023 World Conference on Lung Cancer (WCLC) was held in Singapore from September 9 to 12. The “Oncology Frontier” team delved into the frontlines, capturing international advancements,…